ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors

Cancer Research

Volumn 69, Issue 21, 2009, Pages 8491-8498

  Ciró, Marco ^a   Prosperini, Elena ^a   Quarto, Micaela ^b   Grazini, Ursula ^a   Walfridsson, Julian ^c,d   McBlane, Fraser ^a   Nucifero, Paolo ^b   Pacchiana, Giovanni ^a   Capra, Maria ^b   Christensen, Jesper ^c,d   Helin, Kristian ^a,c,d  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; MYC PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ATAD2; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RECURRENCE; CARCINOGENESIS; CELL CYCLE S PHASE; CHROMOSOME 8Q; CHROMOSOME MAP; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE MYC; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOMES, HUMAN, PAIR 8; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; HISTONES; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; NEOPLASM METASTASIS; NEOPLASMS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED;

EID: 70350537013     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2131     Document Type: Article

References (40)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-847 (Pubitemid 28331029)
3. Lin L, Prescott MS, Zhu Z, et al. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res 2000;60:7021-7027 (Pubitemid 32059179)
4. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999; 18:3004-3016
5. Wallrapp C, Muller-Pillasch F, Solinas-Toldo S, et al. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res 1997;57:3135-3139 (Pubitemid 27351725)
6. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005;6:635-645 (Pubitemid 41081267)
7. Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet 1999;22:102-105 (Pubitemid 29214815)
8. Vervoorts J, Luscher-Firzlaff JM, Rottmann S, et al. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep 2003;4:484-490 (Pubitemid 36789847)
9. Flinn EM, Wallberg AE, Hermann S, Grant PA, Workman JL,Wright AP. Recruitment of Gcn5-containing complexes during c-Myc-dependent gene activation. Structure and function aspects. J Biol Chem 2002;277:23399-23406 (Pubitemid 34952171)
10. McMahon SB, Wood MA, Cole MD. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 2000;20:556-562
11. Frank SR, Parisi T, Taubert S, et al. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 2003;4:575-580 (Pubitemid 36939948)
12. Carnero A, Hudson JD, Price CM, Beach DH. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2000;2:148-155 (Pubitemid 30781129)
13. Whitfield ML, Sherlock G, Saldanha AJ, et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 2002;13:1977-2000. (Pubitemid 34651487)
14. Rubinson DA, Dillon CP, Kwiatkowski AV, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003;33:401-406 (Pubitemid 36278858)
15. Helin K, Wu CL, Fattaey AR, et al. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev 1993;7:1850-1861 (Pubitemid 23312940)
16. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. Binding of c-Myc to chromatin mediates mitogen- induced acetylation of histone H4 and gene activation. Genes Dev 2001;15:2069-2082 (Pubitemid 32762051)
17. Fernandez PC, Frank SR, Wang L, et al. Genomic targets of the human c-Myc protein. Genes Dev 2003;17:1115-1129 (Pubitemid 36534986)
18. He DC, Nickerson JA, Penman S. Core filaments of the nuclear matrix. J Cell Biol 1990;110:569-580
19. Christensen J, Tattersall P. Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system. J Virol 2002;76:6518-6531 (Pubitemid 34633518)
20. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 2003;22:5323-5335 (Pubitemid 37279943)
21. Neuwald AF, Aravind L, Spouge JL, Koonin EV. AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res 1999;9:27-43. (Pubitemid 29095146)
22. Zeng L, Zhou MM. Bromodomain: an acetyl-lysine binding domain. FEBS Lett 2002;513:124-128
23. Zou JX, Guo L, Revenko AS, et al. Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer. Cancer Res 2009;69:3339-3346
24. Zou JX, Revenko AS, Li LB, Gemo AT, Chen HW. ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERα, is required for coregulator occupancy and chromatin modification. Proc Natl Acad Sci U S A 2007; 104:18067-18072
25. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511 (Pubitemid 30082188)
26. Chen X, Cheung ST, So S, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002;13: 1929-1939 (Pubitemid 34651483)
27. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 2003;100:5974-5979 (Pubitemid 36576916)
28. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 2001;98:15149-15154 (Pubitemid 34013984)
29. van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536
30. Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 2002;99:12963-12968
31. Vigo E, Muller H, Prosperini E, et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol 1999;19:6379-6395 (Pubitemid 29399342)
32. Schwartz MA, Assoian RK. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 2001;114: 2553-2560
33. Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM. Structure and ligand of a histone acetyltransferase bromodomain. Nature 1999;399:491-496 (Pubitemid 29258857)
34. Crawley JJ, Furge KA. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data. Genome Biol 2002;3: RESEARCH0075.
35. Robanus-Maandag EC, Bosch CA, Kristel PM, et al. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas. J Pathol 2003;201:75-82.
36. Petroziello J, Yamane A, Westendorf L, et al. Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in nonsmall-cell lung cancer. Oncogene 2004;23:7734-7745 (Pubitemid 39424932)
37. Lucito R, Healy J, Alexander J, et al. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res 2003;13:2291-2305 (Pubitemid 37265995)
38. Huang Q, Yu GP, McCormick SA, et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 2002; 34:224-233 (Pubitemid 34578679)
39. Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP, Lam WL. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer. Genes Chromosomes Cancer 2004;39: 93-98 (Pubitemid 37475258)
40. Marmorstein R, Berger SL. Structure and function of bromodomains in chromatin-regulating complexes. Gene 2001;272:1-9. (Pubitemid 32695392)